Codes / ICD10CM / D47.0

D47.0 Mast cell neoplasms of uncertain behavior

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Mast cell neoplasms of uncertain behavior

Summary

Mast cell neoplasms of uncertain behavior represent a group of conditions involving abnormal mast cell growth that does not clearly meet criteria for malignancy but requires monitoring due to potential for progression. These neoplasms may involve localized or systemic involvement, with behavior that is not definitively benign or malignant, necessitating ongoing clinical evaluation.

Causes

The exact causes of mast cell neoplasms of uncertain behavior are not fully understood. They may arise from genetic mutations affecting mast cell development or function, or dysregulated signaling pathways. Environmental triggers or prior mast cell disorders could contribute, but specific etiologies remain unclear.

Risk Factors

  • Age: More common in adults, though pediatric cases occur.
  • Prior mast cell disorders: History of related conditions may increase risk.
  • Genetic predisposition: Familial or inherited factors may play a role.
  • Immune system dysfunction: Conditions affecting immune regulation could contribute.

Symptoms

Symptoms vary depending on the extent and location of the neoplasm. Some cases are asymptomatic, while others may present with:

  • Skin lesions or rashes
  • Abdominal pain or gastrointestinal symptoms
  • Flushing or hypotension
  • Bone pain or fractures
  • Enlarged liver, spleen, or lymph nodes

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and tissue analysis. Blood tests may assess mast cell markers, while imaging (e.g., CT, MRI) evaluates organ involvement. A biopsy of affected tissue, often with immunohistochemical staining, confirms the presence of abnormal mast cells and assesses behavior.

Treatment Options

Treatment depends on the extent and symptoms of the neoplasm. Asymptomatic cases may require monitoring, while symptomatic or progressive disease may involve medications (e.g., antihistamines, mast cell stabilizers) or targeted therapies. Surgical removal may be considered for localized lesions.

Prognosis and Follow-Up

Prognosis varies based on the neoplasm's behavior and response to treatment. Regular follow-up, including clinical exams and imaging, is typically recommended to monitor for progression or transformation. Most cases remain stable, but some may evolve into more aggressive forms requiring adjusted management.

Complications

Potential complications include progression to malignant mast cell disorders, organ damage from mast cell mediator release (e.g., anaphylaxis), or systemic symptoms affecting quality of life. Rarely, severe reactions may occur with triggers like certain medications or foods.

Lifestyle & Prevention

Lifestyle modifications focus on symptom management and avoiding known triggers (e.g., specific foods, medications, or environmental factors that provoke mast cell activation). Maintaining overall health and adhering to follow-up schedules supports early detection of changes.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms occur, such as severe flushing, hypotension, difficulty breathing, or unexplained pain. Prompt evaluation is important for assessing progression or complications.

Tips for Medical Coders

Document the clinical behavior (e.g., uncertain behavior) and any associated symptoms or organ involvement. Ensure coding aligns with the specific mast cell neoplasm type and documentation of monitoring or treatment. Note that this code is for uncertain behavior and not for malignant or benign mast cell disorders.

Book a walkthrough

D47.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.